Rather, the data suggest that the therapeutic effect of hipIg—at least in the neuritis mouse model—is independent on IgG levels, pleiotropic and not only driven by their ability to reduce IgG recycling by FcRn saturation. The gene discussed is FCGRT; the disease is neuritis.